Home › Liver Diseases

Liver Diseases clinical trials recruiting in the U.S.

33 studies for Liver Diseases are recruiting participants at sites across the United States.

Get the facts about liver diseases, such as hepatitis, cancer, and cirrhosis. Know your risk and what you can do to prevent liver problems.

Cities with the most studies

• Houston, TX10 studies
• Chicago, IL9 studies
• Washington, DC8 studies
• Los Angeles, CA7 studies
• Atlanta, GA7 studies
• Philadelphia, PA6 studies
• Richmond, VA6 studies
• New York City, NY6 studies
• San Antonio, TX6 studies
• Durham, NC5 studies
• Ann Arbor, MI5 studies
• Dallas, TX5 studies
• Cincinnati, OH4 studies
• Salt Lake City, UT4 studies
• Aurora, CO4 studies
• Detroit, MI4 studies
• Baltimore, MD4 studies
• Little Rock, AR4 studies
• San Diego, CA4 studies
• Austin, TX4 studies
• Miami, FL4 studies
• St. Louis, MO4 studies
• Chandler, AZ4 studies
• Pittsburgh, PA4 studies
• Cleveland, OH4 studies
• Nashville, TN4 studies
• Orlando, FL4 studies
• Boston, MA3 studies
• Seattle, WA3 studies
• Huntington Beach, CA3 studies
• Brownsville, TX3 studies
• Round Rock, TX3 studies
• Fayetteville, NC3 studies
• Dayton, OH3 studies
• Monroe, LA3 studies
• Hialeah, FL3 studies
• Peoria, AZ3 studies
• Orange, CA3 studies
• Memphis, TN3 studies
• Ocala, FL3 studies

By state

• Arizona5 studies
• Arkansas4 studies
• California12 studies
• Colorado6 studies
• Florida8 studies
• Georgia8 studies
• Illinois10 studies
• Indiana5 studies
• Kansas3 studies
• Kentucky3 studies
• Louisiana3 studies
• Maryland9 studies
• Massachusetts5 studies
• Michigan8 studies
• Minnesota3 studies
• Missouri5 studies
• Nevada3 studies
• New Jersey3 studies
• New York7 studies
• North Carolina6 studies
• Ohio7 studies
• Pennsylvania8 studies
• South Carolina3 studies
• Tennessee5 studies
• Texas14 studies
• Utah6 studies
• Virginia6 studies
• Washington3 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.